The global market for Energy-based Ablation Devices in 2009 was estimated to be about $9,891.2 million. Ablation is considered to be a therapeutic destruction and sealing of tissue and are readily segmented by technology:
- Thermal (other than cryotherapy)
Well established technologies like radiation and laser are giving way to the emerging modalities of cryotherapy and radiofrequency ablation, which are demonstrating safety, clinical utility and sufficient ease of use to be adopted by a wide range of specialists.
Source: MedMarket Diligence, LLC; Report #A145.